Disclaimer

The U.S. Food and Drug Administration (FDA) has not approved the BrainGate Neural Interface System for general use.

The BrainGate System is an investigational device in the United States, and is under IDE status (Investigational Device Exemption). In the United States, this investigational product can only be used in pre-marketing clinical trials approved by the FDA. For further information, please contact Cyberkinetics Neurotechnology Systems, Inc.

This web site is intended to comply with U.S. laws and regulations. While accessible to users outside of the U.S., the information on this web site is intended for use only by residents of the U.S.